Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2021, Vol. 35 ›› Issue (1): 30-34.doi: 10.6040/j.issn.1673-3770.0.2020.127
Previous Articles Next Articles
SHI Shujing, FANG Jinglei, ZHANG Anqi, XU Li, LIU Ranran, HAN Zhenqiang, WANG Jianguo
CLC Number:
[1] Fang GL, Lou HF, Yu WL, et al. Prediction of the originating site of sinonasal inverted Papilloma by preoperative magnetic resonance imaging and computed tomography[J]. Int Forum Allergy Rhinol, 2016, 6(12):1221-1228. doi:10.1002/alr.21836. [2] Nowosielska-Grygiel J, Pietkiewicz P, Owczarek K, et al. Diagnosis and treatment of nasal and paranasal inverted papillomas-epidemiology and own experience[J]. Otolaryngol Pol, 2017, 71(6):27-32. doi:10.5604/01.3001.0010.7195. [3] Akkari M, Lassave J, Mura T, et al. Atypical presentations of sinonasal inverted papilloma: Surgical management and influence on the recurrence rate[J]. Am J Rhinol Allergy, 2016, 30(2):149-154. doi:10.2500/ajra.2016.30.4288. [4] Lu W, Kang YB. Epithelial-mesenchymal plasticity in cancer progression and metastasis[J]. Dev Cell, 2019, 49(3):361-374. doi:10.1016/j.devcel.2019.04.010. [5] Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer[J]. Nat Rev Mol Cell Biol, 2019, 20(2):69-84. doi:10.1038/s41580-018-0080-4. [6] 王艳杰, 耿志刚, 赵长青, 等. 鼻腔鼻窦内翻性乳头状瘤的临床分期及术式选择[J]. 中国中西医结合耳鼻咽喉科杂志, 2020, 28(1):75-79. doi:10.16542/j.cnki.issn.1007-4856.2020.01.020. WANG Yanjie, GENG Zhigang, ZHAO Changqing, et al. The clinical classification systems and surgical methods for sinonasal inverted Papilloma[J]. Chinese Journal of Otorhinolaryngology in Integrative Medicine, 2020, 28(1):75-79. doi:10.16542/j.cnki.issn.1007-4856.2020.01.020. [7] 王愿, 周涵, 刘晓静, 等. 鼻内翻性乳头状瘤的术式选择和疗效分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(2):79-83. doi:10.6040/j.issn.1673-3770.0.2017.441. WANG Yuan, ZHOU Han, LIU Xiaojing, et al. Surgical strategies for nasal inverted Papilloma and corresponding recurrence rates[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(2):79-83. doi:10.6040/j.issn.1673-3770.0.2017.441. [8] Coutinho G, Marques J, Leal M, et al. Surgical outcomes of sinonasal inverted papilloma: a 17 year review[J]. Braz J Otorhinolaryngol, 2020, 86(3):315-320. doi:10.1016/j.bjorl.2018.12.011. [9] Udager AM, McHugh JB, Goudsmit CM, et al. Human papillomavirus(HPV)and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas[J]. Ann Oncol, 2018, 29(2):466-471. doi:10.1093/annonc/mdx736. [10] Derynck R, Weinberg RA. EMT and cancer: more than meets the eye[J]. Dev Cell, 2019, 49(3):313-316. doi:10.1016/j.devcel.2019.04.026. [11] Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: how does cadherin dysfunction promote tumor progression?[J]. Oncogene, 2008, 27(55):6920-6929. doi:10.1038/onc.2008.343. [12] Huang RYJ, Guilford P, Thiery JP. Early events in cell adhesion and polarity during epithelial-mesenchymal transition[J]. J Cell Sci, 2012, 125(19):4417-4422. doi:10.1242/jcs.099697. [13] Webber HC, Bermudez JY, Millar JC, et al. The role of wnt/β-catenin signaling and K-cadherin in the regulation of intraocular pressure[J]. Invest Ophthalmol Vis Sci, 2018, 59(3):1454. doi:10.1167/iovs.17-21964. [14] 杜刚, 黄瑛. 膀胱癌组织中PVRL4、NF-κB p65、E-cadherin的表达变化及意义[J]. 山东医药, 2019, 59(28):29-32. doi:10.3969/j.issn.1002-266X.2019.28.007. DU Gang, HUANG Ying. Expression and clinical significance of PVRL4, NF-κB p65 and E-cadherin in bladder cancer tissues[J]. Shandong Medical Journal, 2019, 59(28):29-32. doi:10.3969/j.issn.1002-266X.2019.28.007. [15] 谭红, 毛亮, 王敏, 等. E-钙黏素mRNA在大鼠舌黏膜癌变过程中的表达研究[J]. 口腔医学研究, 2016, 32(1):31-34. doi:10.11839/kqyxzh.2016.01.008. TAN Hong, MAO Liang, WANG Min, et al. expression of E-cadherin mRNA in the rat tongue carcinogenesis[J]. Journal of Oral Science Research, 2016, 32(1):31-34. doi:10.11839/kqyxzh.2016.01.008. [16] 孙菊杰, 魏玲, 张德贤, 等. 非小细胞肺癌中Snail、HIF-1α和E-cadherin 表达的临床意义及相关性[J]. 肿瘤防治研究, 2015, 42(1):37-40. doi:10.3971/j.issn.1000-8578.2015.01.009. SUN Jujie, WEI Ling, ZHANG Dexian, et al. Clinical significance of snail, hypoxia-induced factor-1α and E-cadherin expression in non-small cell lung cancer and their correlations[J]. Cancer Research on Prevention and Treatment, 2015, 42(1):37-40. doi:10.3971/j.issn.1000-8578.2015.01.009. [17] Olson A, Le V, Aldahl J, et al. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression[J]. PLoS Genet, 2019, 15(10):e1008451. doi:10.1371/journal.pgen.1008451. [18] Goossens S, Wang J, Tremblay CS, et al. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms[J]. Haematologica, 2019, 104(8):1608-1616. doi:10.3324/haematol.2018.207837. [19] DaSilva-Arnold SC, Kuo CY, Davra V, et al. ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation[J]. Mol Hum Reprod, 2019, 25(2):61-75. doi:10.1093/molehr/gay053. [20] Li Y, Zhang JL, Zhang W, et al. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1[J]. J Mol Histol, 2017, 48(5/6):357-366. doi:10.1007/s10735-017-9734-3. [21] Ji H, Sang MX, Liu F, et al. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer[J]. Pathol-Res Pract, 2019, 215(4):697-704. doi:10.1016/j.prp.2018.12.039. [22] Suzuki K, Kawataki T, Endo K, et al. Expression of ZEBs in gliomas is associated with invasive properties and histopathological grade[J]. Oncol Lett, 2018, 16(2):1758-1764. doi:10.3892/ol.2018.8852. [23] Li XT, Li CH, Bi HM, et al. Targeting ZEB2 by microRNA-129 in non-small cell lung cancer suppresses cell proliferation, invasion and migration via regulating wnt/β-catenin signaling pathway and epithelial-mesenchymal transition[J]. Onco Targets Ther, 2019, 12:9165-9175. doi:10.2147/OTT.S217536. [24] Chen XF, Guo JF, Xu JF, et al. MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2[J]. Eur Rev Med Pharmacol Sci, 2019, 23(18):7826-7834. doi:10.26355/eurrev_201909_18992. [25] Hu B, Sun M, Liu J, et al. MicroRNA-204 suppressed proliferation and motility capacity of human hepatocellular carcinoma via directly targeting zinc finger E-box binding homeobox 2[J]. Oncol Lett, 2017, 13(5):3823-3830. doi:10.3892/ol.2017.5907. [26] Kan QE, Su Y, Yang HH. MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2[J]. Oncol Lett, 2017, 14(6):7622-7628. doi:10.3892/ol.2017.7126. |
[1] | MA Jingyuan, WU Tianyi, SUN Zhanwei, WANG Weiwei, LI Shichao, WANG Guangke. Correlation between sinonasal inverted papilloma and peripheral inflammatory blood markers [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 35-39. |
[2] | JIN Peng1, LI Chun-wei2, LI Ying-ying2, ZHAO Li1, WANG De-yun2, SHI Li3. Expression of EMP1 in sinonasal inverted papilloma and its relationship with metaplasia [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(2): 72-75. |
[3] | GUO Zhi-juan1, LI Pei-hua1, ZHANG Xiao-wen2. Prognostic significance of epithelial-mesenchymal transition state in patients with chronic sinusitis treated under endoscopy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 34-38. |
|